All Stories

  1. Safety and tolerability of one-year intramuscular testosterone regime to induce puberty in older men with CHH
  2. Hypernatraemic hypovolaemia with anaemia: an unusual presentation of primary testicular insufficiency
  3. Non-menopausal endocrine and non-endocrine causes of flushing and sweating
  4. Hematopoiesis Shows Closer Correlation with Calculated Free Testosterone in Men than Total Testosterone
  5. TRANSITION IN ENDOCRINOLOGY: Induction of puberty
  6. Saving lives of in‐patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle‐upon‐Tyne Hospitals e‐Prescribing platform
  7. Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms
  8. TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years
  9. Kallmann syndrome, gender dysphoria, thrombophilia and multiple sclerosis: a complex case report
  10. Reversal and Relapse of Hypogonadotropic Hypogonadism: Resilience and Fragility of the Reproductive Neuroendocrine System
  11. Residual Adrenal Function in Autoimmune Addison's Disease: Improvement After Tetracosactide (ACTH1–24) Treatment
  12. Reversal of isolated hypogonadotropic hypogonadism: long‐term integrity of hypothalamo–pituitary–testicular axis in two men is dependent on intermittent androgen exposure
  13. Pubertal induction in adult males with isolated hypogonadotropic hypogonadism using long-acting intramuscular testosterone undecanoate 1-g depot (Nebido®)
  14. The usefulness of metformin for diabetes control in older people
  15. Prioritizing Genetic Testing in Patients With Kallmann Syndrome Using Clinical Phenotypes
  16. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic Hypogonadism
  17. A UK epidemic of testosterone prescribing, 2001–2010
  18. Obesity-related hypogonadotrophic hypogonadism: recovery of normal pituitary[ndash]gonadal axis function following bariatric surgery
  19. Pubertal induction in males with hypogonadotropic hypogonadism using long-acting intramuscular testosterone undecanoate 1g depot (Nebido)
  20. Revival of adrenal function in established autoimmune Addison's disease
  21. Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH)
  22. Kallmann syndrome
  23. When Genetic Load Does Not Correlate with Phenotypic Spectrum: Lessons from the GnRH Receptor (GNRHR)
  24. GnRH-Deficient Phenotypes in Humans and Mice With Heterozygous Variants in KISS1/Kiss1
  25. Many men are receiving unnecessary testosterone prescriptions
  26. Communication skills & overseas medical graduates
  27. Where specialist diabetes teams can be found
  28. Vitamin D testing
  29. Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic Dysplasia
  30. GnRH-Deficient Phenotypes in Humans and Mice with Heterozygous Variants inKISS1/Kiss1
  31. The kisspeptin signaling pathway and its role in human isolated GnRH deficiency
  32. A Genetic Basis for Functional Hypothalamic Amenorrhea
  33. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory
  34. Expanding the Phenotype and Genotype of Female GnRH Deficiency
  35. Expanding the Phenotype and Genotype of Female GnRH Deficiency
  36. Expanding the Phenotype and Genotype of Female GnRH Deficiency
  37. A Genetic Basis for Functional Hypothalamic Amenorrhea
  38. Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation
  39. TAC3/TACR3Mutations Reveal Preferential Activation of Gonadotropin-Releasing Hormone Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  40. TAC3/TACR3Mutations Reveal Preferential Activation of GnRH Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  41. TAC3/TACR3Mutations Reveal Preferential Activation of GnRH Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  42. Physiological Significance of the Rhythmic Secretion of Hypothalamic and Pituitary Hormones
  43. Biology of <i>KAL1</i> and Its Orthologs: Implications for X-Linked Kallmann Syndrome and the Search for Novel Candidate Genes
  44. Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma
  45. Two myths
  46. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  47. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  48. Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  49. The story of Axel Munthe
  50. Estrogen biosynthesis in human H295 adrenocortical carcinoma cells
  51. Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations
  52. Health‐Related Quality of Life Instruments in Studies of Adult Men with Testosterone Deficiency Syndrome: A Critical Assessment
  53. Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome
  54. Mutations inProkineticin 2andProkineticin receptor 2genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical Spectrum
  55. Time to go to get your hat
  56. Congenital radioulnar synostosis, azoospermia, and pseudodicentric Y chromosome
  57. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice
  58. Unrecognised severe vitamin D deficiency
  59. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
  60. Chapter 9 Puberty and fertility
  61. Chapter 5 Secondary hypogonadism
  62. The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
  63. Insulin resistance causing severe postmenopausal hyperandrogenism
  64. Reversal of Idiopathic Hypogonadotropic Hypogonadism
  65. Genomic Polymorphism at the Interferon-Induced Helicase (IFIH1) Locus Contributes to Graves’ Disease Susceptibility
  66. The Burden of Testosterone Deficiency Syndrome in Adult Men: Economic and Quality-of-Life Impact
  67. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism
  68. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes
  69. Advice in ABC of adolescence is potentially misleading
  70. Kallmann's Syndrome: Bridging the Gaps
  71. Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases
  72. Endocrinology and systemic disease
  73. Kallmann Syndrome
  74. GnRH neuronal development: insights into hypogonadotrophic hypogonadism
  75. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization*
  76. Routine neuroimaging in classical isolated gonadotrophin deficiency is of limited clinical value
  77. Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin‐releasing hormone
  78. Kallmann's syndrome: is it always for life?
  79. Adult onset idiopathic hypogonadotrophic hypogonadism may be overdiagnosed
  80. Contrasting Expression ofKALin Cell-Free Systems: 5′ UTR and Coding Region Structural Effects on Translation
  81. Gonadotropin-Releasing Hormone Immunoreactivity in the Nasal Epithelia of Adults with Kallmann’s Syndrome and Isolated Hypogonadotropic Hypogonadism and in the Early Midtrimester Human Fetus
  82. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis [published erratum appears in J Clin Endocrinol Metab 1996 Oct;81(10):3614]
  83. Molecular Genetics and Neurobiology of Kallmann’s Syndrome
  84. Identification of olfactory dysfunction in carriers of X‐linked Kallmann's syndrome
  85. Unilateral renal aplasia in X‐linked Kallmann's syndrome
  86. Kallmannʼs syndrome
  87. Successful induction of fertility in a hypogonadotropic male
  88. Renal AA amyloidosis in a patient with Bence Jones proteinuria and ankylosing spondylitis.